Awakn Research



Scroll-Down-white

Our research and development team consists of world leading experts in the fields of drug development, clinical research, psychiatry, and psychotherapy.

This team, building on its own substantial innovative research, supported by experienced consultants and a network of leading international contract/clinical research organisations, is building a pipeline of new therapies and drug candidates (designed to be used in conjunction with psychotherapy). We focus our research and development activities on treating addictions where the consequences for the patient, their family and society are at present most severe, with near, medium, and long terms programs.

Untitled-1

NEAR TERM

Ketamine

Ketamine-Assisted Psychotherapy for Alcohol Use Disorder

MEDIUM TERM

MDMA

MDMA-Assisted Psychotherapy for Alcohol Use Disorder

LONG TERM

New Chemical Entities

Alcohol, Behavioural, Opioid, and Tobacco addictions

Our therapy and drug development pipeline

Asset-11

Sign Up for Newsletter:

MAIN OFFICE
Suite 200, 366 Bay St,
Toronto, Ontario, M5H 4B2, Canada

UK OFFICE
1 Regent Street,
Bristol, BS8 4HW, United Kingdom

© 2021 Awakn Life Sciences Corp      |      Privacy Policy      |      Appropriate Use Policy